Skynor Medical, headquartered in China, is a leading player in the medical technology industry, specialising in innovative healthcare solutions. Founded in 2010, the company has rapidly expanded its operations across Asia and Europe, establishing a strong presence in the medical device sector. Skynor Medical is renowned for its advanced diagnostic equipment and patient monitoring systems, which are distinguished by their cutting-edge technology and user-friendly design. The company’s commitment to quality and innovation has earned it a reputable position in the market, with notable achievements including several industry awards for excellence in product development. With a focus on enhancing patient care and improving clinical outcomes, Skynor Medical continues to push the boundaries of medical technology, making significant contributions to the healthcare landscape.
How does Skynor Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Skynor Medical's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Skynor Medical, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Skynor Medical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate commitments and reduction strategies to align with global efforts to mitigate climate change.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Skynor Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

